ABA Life signs MAD 400m investment agreement with Admaius
The Moroccan health technology business plans to expand clinical AI, industrial capacity and international operations.
ABA Life announced a 400 million Moroccan dirham investment agreement with Admaius Capital Partners on 26 October 2026. The transaction will provide new equity capital to the healthcare arm of ABA Technology, according to the company and investor. Completion remains subject to customary closing conditions and clearance from Morocco’s Competition Council.
The capital will support ABA Life’s AI for Sovereign Health programme, including the Mediot AI platform and clinical intelligence solutions. It will also fund the industrialisation and deployment of healthcare technologies and services, alongside international expansion.
ABA Life combines medical devices, connected infrastructure, telemedicine and healthcare operations. ABA Technology will retain a substantial majority holding and operational control, while the precise minority stake will depend on the agreed transaction terms.